LATEST
EQT agreed to acquire CleanawayNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire OdidoGTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire Stockbridge
Open App
Agreement signedPublished 2 Jun 2025

GSK /
Theravance Biopharma, Inc.

GSK agrees to buy Theravance Biopharma, Inc.

Buy side: GSK
Buy sideGSK
Target: Theravance Biopharma, Inc.
TargetTheravance Biopharma, Inc.
Source · 2 Jun 2025Source-verified
See the source
Buy side: GSK
Buy sideGSK
Target: Theravance Biopharma, Inc.
TargetTheravance Biopharma, Inc.
01 / BuyerGSK
02 / TargetTheravance Biopharma, Inc.
Source-verified
01

What happened

GSK agreed to acquire Theravance Biopharma, Inc. for $225 million, according to a filing dated June 2, 2025.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

GSK agrees to buy Theravance Biopharma, Inc.

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.